Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Anal Biochem ; 205(2): 213-9, 1992 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1332539

RESUMEN

A new, highly sensitive radioreceptor assay, which does not require high-performance liquid chromatography, has been developed for the determination of 1,25-dihydroxyvitamin D3 (1,25-(OH2)D3) in serum. The assay involves rapid extraction of serum, Sep Pak silica purification, and addition of 1,25-dihydroxyvitamin D3 receptor, radiolabeled 1,25-dihydroxyvitamin D3, bovine serum albumin, and monoclonal antibody to specifically precipitate the receptor. This method is sensitive to 0.3-0.6 pg/tube, with B50 occurring at 5.8 pg/tube. This sensitivity combined with overall recovery of 1,25-dihydroxyvitamin D3 (81.5 +/- 5.2%, n = 50, mean +/- SD) allows the measurement of serum 1,25-(OH)2D3 in duplicates with only 0.5 ml of serum. Intra- and interassay coefficient of variation were 9.5 and 14.6%, respectively. Dilution analysis, analytical recovery of added 1,25-dihydroxyvitamin D3, and comparison with a standard method using HPLC have been used to validate the assay. Serum 1,25-dihydroxyvitamin D3 level was for normal adults, 36.6 +/- 10.5 pg/ml (n = 14); in primary hyperparathyroidism, 98.9 +/- 19.9 pg/ml (n = 16); in chronic renal failure, 17.8 +/- 5.1 pg/ml (n = 12). This method allows large numbers of samples to be processed at once. Further, the method is rapid and provides an accurate assay using small amounts of serum.


Asunto(s)
Anticuerpos Monoclonales/análisis , Calcitriol/sangre , Ensayo de Unión Radioligante/métodos , Receptores de Esteroides/inmunología , Administración Oral , Animales , Cromatografía Líquida de Alta Presión , Humanos , Hidroxicolecalciferoles/administración & dosificación , Hiperparatiroidismo/sangre , Intestinos , Masculino , Ratas , Ratas Wistar , Receptores de Calcitriol , Porcinos
2.
J Nutr ; 122(6): 1338-44, 1992 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1588451

RESUMEN

We performed experiments to determine whether treatment with vitamin D or 1,25-dihydroxycholecalciferol could reverse male infertility caused by vitamin D deficiency. Additionally, an attempt was made to distinguish between a direct and an indirect effect of 1,25-dihydroxycholecalciferol on reproductive tissue. Vitamin D-deficient male rats with impaired fertility were treated with vitamin D and 1,25-dihydroxycholecalciferol for 3 wk, then mated. Secondly, vitamin D-deficient male rats were made normocalcemic by increasing dietary calcium, and their fertility was compared with that of vitamin D-deficient, hypocalcemic rats. The fertility of male rats was restored by treatment with either vitamin D or 1,25-dihydroxycholecalciferol. However, fertility was also restored in vitamin D-deficient animals by feeding them a diet supplemented with high levels of calcium. These results indicate that the influence of vitamin D and its active metabolite, 1,25-dihydroxycholecalciferol, on male fertility is indirect. Vitamin D and 1,25-dihydroxycholecalciferol seemed to influence male fertility by acting on classic target tissues and regulating levels of calcium in reproductive tissues.


Asunto(s)
Calcio/sangre , Infertilidad Masculina/etiología , Deficiencia de Vitamina D/complicaciones , Animales , Calcitriol/uso terapéutico , Calcio/administración & dosificación , Calcio/uso terapéutico , Femenino , Infertilidad Masculina/sangre , Infertilidad Masculina/tratamiento farmacológico , Masculino , Ratas , Ratas Endogámicas , Vitamina D/uso terapéutico , Deficiencia de Vitamina D/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA